Am Donnerstag, den 15.8. kann es zwischen 16 und 18 Uhr aufgrund von Wartungsarbeiten des ZIM zu Einschränkungen bei der Katalognutzung kommen.
Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
Open Access
    Datensatz exportieren als...
  • BibTeX
Penile cancer: current therapy and future directions
Annals of oncology, 2013-05, Vol.24 (5), p.1179-1189
2013
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Management and challenges of corticosteroid therapy in men with metastatic castrate-resistant prostate cancer
Annals of oncology, 2013-01, Vol.24 (1), p.31-38
2013
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Patient experience in the treatment of metastatic castration-resistant prostate cancer: state of the science
Prostate cancer and prostatic diseases, 2016-06, Vol.19 (2), p.111-121
2016
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
A review of clinical effects associated with metabolic syndrome and exercise in prostate cancer patients
Prostate cancer and prostatic diseases, 2016-12, Vol.19 (4), p.323-332
2016
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Speeding dating for docetaxel and recent debutantes in castration-resistant prostate cancer: ‘plus or minus’ may be a minus
Annals of oncology, 2013-02, Vol.24 (2), p.270-272
2013
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Prostatectomy at high-volume centers improves outcomes and lowers the costs of care for prostate cancer
Prostate cancer and prostatic diseases, 2016-03, Vol.19 (1), p.84-91
2016
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Non-metastatic castration-resistant prostate cancer (nmCRPC): Meta-analysis of efficacy and safety with novel hormonal agents apalutamide and enzalutamide
Annals of oncology, 2018-10, Vol.29, p.viii279-viii279
2018
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Phase II California Cancer Consortium trial of gemcitabine–eribulin combination (GE) in cisplatin ineligible patients (pts) with metastatic urothelial carcinoma (mUC): tolerability and toxicity report (NCI-9653; 1UM1CA186717-01, NO1-CM-2011-00038)
European journal of cancer (1990), 2017-02, Vol.72, p.S197-S197
2017
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
2539 A phase II trial of AEZS-108 in castration and taxane resistant prostate cancer
European journal of cancer (1990), 2015-09, Vol.51, p.S488-S488
2015
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
A first-in-human phase I study of sEphB4-HSA in patients with advanced solid tumors with expansion at the maximum tolerated dose (MTD) or recommended phase II dose (RP2D)
European journal of cancer (1990), 2016-12, Vol.69, p.S11-S11
2016
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Health-Related Quality Of Life In Metastatic Castration-Resistant Prostate Cancer: A Critical Literature Review
Value in health, 2015-05, Vol.18 (3), p.A211-A211
2015
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
A Phase II trial of a combination herbal supplement for men with biochemically recurrent prostate cancer
Prostate cancer and prostatic diseases, 2014-12, Vol.17 (4), p.359-365
2014
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Bone-targeted therapies to reduce skeletal morbidity in prostate cancer
Asian journal of andrology, 2018-05, Vol.20 (3), p.215-220
2018
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Real-world analysis of patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving vs not receiving chemotherapy in the treatment sequence
Annals of oncology, 2019-10, Vol.30, p.v334
2019
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
856P - Real-world analysis of patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving vs not receiving chemotherapy in the treatment sequence
Annals of oncology, 2019-10, Vol.30, p.v334-v334
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
1815P Emergent circulating tumor DNA (ctDNA) variants and ctDNA burden dynamics with potential associations with talazoparib antitumor activity in TALAPRO-1
Annals of oncology, 2023-10, Vol.34, p.S983-S984
2023
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
1479P Ultra-sensitive circulating tumor DNA (ctDNA) assay distinguishes partial response (PR) and complete response (CR) with immunotherapy in metastatic renal cell carcinoma (mRCC)
Annals of oncology, 2022-09, Vol.33, p.S1223
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
LBA63 PRESTO: A phase III, open-label study of androgen annihilation in patients (pts) with high-risk biochemically relapsed prostate cancer (AFT-19)
Annals of oncology, 2022-09, Vol.33, p.S1428
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
264P Interim results from a phase I study of AMG 509 (xaluritamig), a STEAP1 x CD3 XmAb 2+1 immune therapy in patients with metastatic castration-resistant prostate cancer (mCRPC)
Annals of oncology, 2023-11, Vol.34, p.S1576
2023
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
1765O Interim results from a phase I study of AMG 509 (xaluritamig), a STEAP1 x CD3 XmAb 2+1 immune therapy, in patients with metastatic castration-resistant prostate cancer (mCRPC)
Annals of oncology, 2023-10, Vol.34, p.S953-S954
2023
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
1564MO Characterization of COVID-19 vaccination response by antibody (Ab) titer and T-cell receptor (TCR) sequencing in patients (pts) with advanced genitourinary (GU) cancers
Annals of oncology, 2021-09, Vol.32, p.S1132-S1132
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
LBA24 Cabozantinib (C) in combination with atezolizumab (A) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Results of expanded cohort 6 of the COSMIC-021 study
Annals of oncology, 2021-09, Vol.32, p.S1299-S1300
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
651O Phase II trial of pembrolizumab (P) in combination with sEphB4-HSA (B4) in previously treated metastatic urothelial carcinoma (mUC)
Annals of oncology, 2021-09, Vol.32, p.S678-S678
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
581P Patient (pt) reported pain in men with metastatic castration-resistant prostate cancer (mCRPC) receiving talazoparib (TALA): TALAPRO-1
Annals of oncology, 2021-09, Vol.32, p.S631-S632
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
1368P TALAPRO-1: Talazoparib monotherapy in metastatic castration-resistant prostate cancer (mCRPC) with DNA damage response alterations (DDRm) – Exploration of tumor genetics associated with prolonged benefit
Annals of oncology, 2022-09, Vol.33, p.S1167
2022
Volltextzugriff (PDF)
1 – 25 von 933
Suche als RSS-Feed
Suchergebnisse filtern
Filter anzeigen
Nur zeigen
Publikationsform
3 weitere anzeigen...
Weniger anzeigen...
Sprache
1 weiteren anzeigen...
Weniger anzeigen...
Erscheinungsjahr
n.n
n.n
Thema
15 weitere anzeigen...
Weniger anzeigen...
Kollektion
15 weitere anzeigen...
Weniger anzeigen...
Zeitschrift / Serie
5 weitere anzeigen...
Weniger anzeigen...
Neu hinzugefügt